HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of estrogen receptor-{beta}-dependent HO-1.

Abstract
Hemeoxygenase (HO)-1 induction following adverse circulatory conditions is known to be protective, and precastrated males have less intestinal damage than sham-operated males following trauma-hemorrhage (T-H). Previous studies have also shown that administration of flutamide up-regulated estrogen receptor (ER) expression in males following T-H. We hypothesized that flutamide administration in males following T-H up-regulates HO-1 via an ER-dependent pathway and protects against intestinal injury. Male Sprague-Dawley rats underwent T-H [mean blood pressure (MBP) 40 mmHg for 90 min and then resuscitation]. A single dose of flutamide (25 mg/kg body weight), with or without an ER antagonist (ICI 182,780), a HO enzyme inhibitor [chromium-mesoporphyrin (CrMP)], or vehicle, was administered subcutaneously during resuscitation. At 2 h after T-H or sham operation, intestinal myeloperoxidase (MPO) activity, intercellular adhesion molecule (ICAM)-1, cytokine-induced neutrophil chemoattractant (CINC)-1, and CINC-3 levels were measured. Intestinal ER-alpha, ER-beta, androgen receptor, and HO-1 mRNA/protein levels were also determined. Results showed that T-H increased intestinal MPO activity, ICAM-1, CINC-1, and CINC-3 levels. These parameters were improved significantly in the flutamide-treated rats subjected to T-H. Flutamide treatment increased intestinal HO-1 and ER-beta mRNA/protein levels as compared with vehicle-treated T-H rats. Administration of the ER antagonist ICI 182,780 or the HO inhibitor CrMP prevented the flutamide-induced attenuation of shock-induced intestinal damage. Thus, the salutary effects of flutamide administration on attenuation of intestinal injury following T-H are mediated via up-regulation of ER-beta-dependent HO-1 expression.
AuthorsHuang-Ping Yu, Mashkoor A Choudhry, Tomoharu Shimizu, Ya-Ching Hsieh, Martin G Schwacha, Shaolong Yang, Irshad H Chaudry
JournalJournal of leukocyte biology (J Leukoc Biol) Vol. 79 Issue 2 Pg. 277-84 (Feb 2006) ISSN: 0741-5400 [Print] United States
PMID16330533 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Chemokine CXCL1
  • Chemokines, CXC
  • Cxcl1 protein, rat
  • Enzyme Inhibitors
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Mesoporphyrins
  • RNA, Messenger
  • chromium mesoporphyrin
  • Intercellular Adhesion Molecule-1
  • Fulvestrant
  • Estradiol
  • Flutamide
  • Peroxidase
  • Heme Oxygenase-1
Topics
  • Animals
  • Chemokine CXCL1
  • Chemokines, CXC (metabolism)
  • Enzyme Activation (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Estradiol (analogs & derivatives, pharmacology)
  • Estrogen Receptor alpha (antagonists & inhibitors, metabolism)
  • Estrogen Receptor beta (antagonists & inhibitors, genetics, metabolism)
  • Flutamide (administration & dosage, antagonists & inhibitors)
  • Fulvestrant
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Heme Oxygenase-1 (antagonists & inhibitors, genetics, metabolism)
  • Hemorrhage (physiopathology)
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Intestines (drug effects, enzymology, injuries)
  • Male
  • Mesoporphyrins (pharmacology)
  • Peroxidase (drug effects, metabolism)
  • RNA, Messenger (drug effects, genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: